EFTR

Price Data

Effector Therapeutics Inc (EFTR) is a clinical-stage biopharmaceutical company focused on pioneering targeted cancer therapies through the selective modulation of RNA translation. By innovatively altering protein synthesis within tumor cells, the company aims to address significant unmet needs in oncology with its portfolio of small molecule treatments. With a diverse pipeline of product candidates under development, Effector Therapeutics is committed to advancing precision medicine, striving to enhance treatment outcomes and quality of life for cancer patients in a rapidly evolving biotechnology environment.